Malta vs Norway: Proportion of isolates with decreased susceptibility or resistance
Malta
0
in 2018
Norway
0
in 2018
Malta rank
15th
Norway rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Malta
- Norway
How they compare
Malta currently reports 0 against 0 in Norway, a difference of 0.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Norway ahead.
Malta ranks 15th and Norway ranks 15th of 27 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.9091 | 0.9091 | Norway |
| 2010s | 0.8547 | 2.98 | 2.12 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Malta or Norway?
- Malta, at 0 against 0 in Norway as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Malta and Norway?
- 0, with Malta ahead.
- How many years of comparable data are there for Malta and Norway?
- 10 years are reported by both, from 2009 to 2018.
- How do Malta and Norway rank globally for proportion of isolates with decreased susceptibility or resistance?
- Malta ranks 15th and Norway ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.